NOS3 and cardiovascular disorder: The downregulation of eNOS expression and activity leads to decreased NO availability along with decreased PGI2 production, contributing to endothelial dysfunction, increased vascular resistance, and heightened susceptibility to cardiovascular diseases (Sena et al., 2013).